Ozempic Ears and GLP-1 Weight Loss: Dr. Daniel Gould Featured in The Daily Beast

Beverly Hills plastic surgeon Dr. Daniel Gould, MD, PhD was recently featured in The Daily Beast discussing the growing number of patients seeking cosmetic procedures after significant weight loss from GLP-1 medications such as Ozempic, Wegovy, and Mounjaro.

In the article, Dr. Gould explains how rapid weight loss can affect more than just the face and body. Patients may also experience volume loss in the ears, a phenomenon commonly referred to as “Ozempic ears.” As facial fat and soft tissue diminish, the ears can appear thinner, flatter, and less youthful.

According to Dr. Gould, restoring volume to the earlobes can be an important component of comprehensive facial rejuvenation. In some patients undergoing facelift surgery after major weight loss, fat transfer can be used to restore fullness to the ears and create a more balanced, natural appearance.

The article explores the increasing demand for cosmetic procedures among GLP-1 users experiencing age-related changes accelerated by rapid weight loss. These changes may include loose skin, facial volume loss, and tissue deflation that can affect overall facial harmony. Treatment options may include fat grafting, facelift surgery, neck lift procedures, and other facial rejuvenation techniques tailored to the individual patient.

As GLP-1 medications continue to help patients achieve significant weight loss, plastic surgeons are seeing a growing need for procedures that address the aesthetic effects of rapid body transformation. Dr. Gould emphasizes the importance of personalized treatment planning and a comprehensive approach to facial rejuvenation following weight loss.